Innovo Therapeutics Inc.

“ The Ultimate Solution,

Propose a new standard of anti-hair loss care with the proven science & technology

First, One&Only Patented ingredients
: Multi-targeted functional cosmetics for anti-hair loss
: TrinogeniX™ (3 patented ingredients)
Second, Proven efficacy and safety
: Clinically proven efficacy and safety
: Provision of new standard of hair loss efficacy
Third, Continuous scientific research
: Academic approach to explore the innovative solution for hair loss
: Deep dive into the customers’ needs to find the best option

APEX of Hair Science : Trinogenix™ The complex of 3 patented ingredients

Confidence-filled, Abundant life

Visionary Pioneer
Set the new standard of hair loss solution
New Challenger
Multi-target approach to the complicated
mechanism of hair loss
Confidence Booster
Fill the motivation and confidence to life
Revolutionary Care
Provide One & Only scientific solution for hair loss

Motifull Hair-Boosting Ampoule tonic

  • ∙ Size: 15ml / 0.51 fl. oz.
  • ∙ A concentrated ampoule tonic that restores scalp and root health while helping reduce hair loss

Motifull Hair-Boosting Ampoule tonic

  • ∙ Size: 50ml / 1.69 fl. oz .
  • ∙ A concentrated ampoule tonic that restores scalp and root health while helping reduce hair loss

Motifull Hair Boosting Shampoo

  • ∙ Size: 485 ml / 16.4 fl. oz.
  • ∙ Scalp cleansing hair loss care shampoo for strengthening weak scalp and hair

Motifull Hair Boosting Treatment

  • ∙ Size: 200 ml / 6.76 fl. oz.
  • ∙ 4-in-1 treatment for thinning hair, scalp care, volume boost, and texture improvement
Motifull Motifull
인증서

Company Introduction

Innovation toward conquering human diseases
I’m pleased to introduce our company to you eventually.

Innovo Therapeutics is a biotech company established by multiple experts with more than 20 years of experience in new drug development, focusing on NCE (new chemical entity) discovery.

Our goal is to develop new drugs for patients suffering from intractable diseases such as idiopathic pulmonary fibrosis, osteoarthritis, ulcerative colitis, etc.

Our primary research field is fibrosis, inflammation, immunology and oncology.

Innovo has developed DeepZema®, an AI-augmented drug development platform, with all our efforts because we acknowledge how critical minimizing errors and increasing success rates in the new drug development process is. In addition, the expertise of the research faculty leads to the acceleration of R&D projects.

Our fundamental objective of starting a new company was centered around caring for patients. This will never change. We always do our best to make our development outcomes ready for patients in the market as fast as possible.

We, employees of Innovo Therapeutics, want to share our promise to be the leading bio-company shortly, keeping a high level of our contribution to human health & life.

Thank you,
GENERALMEMBER
  • Response Level
      less than 30%
  • Supplier Level
      Less than 100 million (KRW)
  • Transaction Level
      less than 5